株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の研究用抗体市場規模、シェア、動向分析:製品別、タイプ別(モノクローナル、ポリクローナル)、技術別、ソース別、用途別(腫瘍、神経)、エンドユース別動向、セグメント予測

Research Antibodies Market Size, Share & Trends Analysis Report By Product, By Type (Monoclonal, Polyclonal), By Technology, By Source, By Application (Oncology, Neurobiology), By End-use, And Segment Forecasts, 2018 - 2025

発行 Grand View Research, Inc. 商品コード 640062
出版日 ページ情報 英文 142 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.69円で換算しております。
Back to Top
世界の研究用抗体市場規模、シェア、動向分析:製品別、タイプ別(モノクローナル、ポリクローナル)、技術別、ソース別、用途別(腫瘍、神経)、エンドユース別動向、セグメント予測 Research Antibodies Market Size, Share & Trends Analysis Report By Product, By Type (Monoclonal, Polyclonal), By Technology, By Source, By Application (Oncology, Neurobiology), By End-use, And Segment Forecasts, 2018 - 2025
出版日: 2018年03月22日 ページ情報: 英文 142 Pages
概要

当レポートでは、世界の研究用抗体市場について調査し、市場の現状と成長予測、製品別、タイプ別、技術別、ソース別、用途別、エンドユース別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 調査方法と範囲

第3章 市場変数、動向、範囲

  • 市場セグメンテーションと範囲
  • 市場促進因子
  • 市場阻害因子
  • 浸透と成長見通しマッピング
  • SWOT分析
  • 業界分析

第4章 製品別予測と動向分析

  • 動向分析
  • 一次抗体
  • 二次抗体

第5章 タイプ別予測と動向分析

  • 動向分析
  • モノクローナル抗体
  • ポリクローナル抗体

第6章 技術別予測と動向分析

  • 動向分析
  • 免疫組織化学
  • 免疫蛍光
  • ウェスタンブロッティング
  • フローサイトメトリー
  • 免疫沈降
  • 酵素結合免疫測定法
  • その他

第7章 ソース別予測と動向分析

  • 動向分析
  • マウス
  • ウサギ
  • ヤギ
  • その他

第8章 用途別予測と動向分析

  • 動向分析
  • 感染症
  • 免疫学
  • 腫瘍
  • 幹細胞
  • 神経生物学
  • その他

第9章 エンドユース別予測と動向分析

  • 動向分析
  • 学術研究機関
  • CRO
  • 製薬会社・バイオテクノロジー企業

第10章 地域別市場

  • 市場シェア
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第11章 競合環境

  • 主要企業リスト
  • 企業プロファイル
    • Abcam PLC
    • Bio - Rad Laboratories
    • BD
    • Merck Millipore (Danaher)
    • Lonza Group
    • Thermo Fisher Scientific
    • Cell Signalling Technology, Inc.
    • F.Hoffmann La Roche Ltd.
    • Agilent Technologies
    • PerkinElmer, Inc.
図表

List of Tables

  • TABLE 1 Country share estimation
  • TABLE 2 North America research antibodies market, by product, 2014 - 2025 (USD Million)
  • TABLE 3 North America research antibodies market, by type, 2014 - 2025 (USD Million)
  • TABLE 4 North America research antibodies market, by technology, 2014 - 2025 (USD Million)
  • TABLE 5 North America research antibodies market, by source, 2014 - 2025 (USD Million)
  • TABLE 6 North America research antibodies market, by application, 2014 - 2025 (USD Million)
  • TABLE 7 North America research antibodies market, by end - use, 2014 - 2025 (USD Million)
  • TABLE 8 U.S. research antibodies market, by product, 2014 - 2025 (USD Million)
  • TABLE 9 U.S. research antibodies market, by type, 2014 - 2025 (USD Million)
  • TABLE 10 U.S. research antibodies market, by technology, 2014 - 2025 (USD Million)
  • TABLE 11 U.S. research antibodies market, by source, 2014 - 2025 (USD Million)
  • TABLE 12 U.S. research antibodies market, by application, 2014 - 2025 (USD Million)
  • TABLE 13 U.S. research antibodies market, by end - use, 2014 - 2025 (USD Million)
  • TABLE 14 Canada research antibodies market, by product, 2014 - 2025 (USD Million)
  • TABLE 15 Canada research antibodies market, by type, 2014 - 2025 (USD Million)
  • TABLE 16 Canada research antibodies market, by technology, 2014 - 2025 (USD Million)
  • TABLE 17 Canada research antibodies market, by source, 2014 - 2025 (USD Million)
  • TABLE 18 Canada research antibodies market, by application, 2014 - 2025 (USD Million)
  • TABLE 19 Canada research antibodies market, by end - use, 2014 - 2025 (USD Million)
  • TABLE 20 Europe research antibodies market, by product, 2014 - 2025 (USD Million)
  • TABLE 21 Europe research antibodies market, by type, 2014 - 2025 (USD Million)
  • TABLE 22 Europe research antibodies market, by technology, 2014 - 2025 (USD Million)
  • TABLE 23 Europe research antibodies market, by source, 2014 - 2025 (USD Million)
  • TABLE 24 Europe research antibodies market, by application, 2014 - 2025 (USD Million)
  • TABLE 25 Europe research antibodies market, by end - use, 2014 - 2025 (USD Million)
  • TABLE 26 U.K. research antibodies market, by product, 2014 - 2025 (USD Million)
  • TABLE 27 U.K. research antibodies market, by type, 2014 - 2025 (USD Million)
  • TABLE 28 U.K. research antibodies market, by technology, 2014 - 2025 (USD Million)
  • TABLE 29 U.K. research antibodies market, by source, 2014 - 2025 (USD Million)
  • TABLE 30 U.K. research antibodies market, by application, 2014 - 2025 (USD Million)
  • TABLE 31 U.K. research antibodies market, by end - use, 2014 - 2025 (USD Million)
  • TABLE 32 Germany research antibodies market, by product, 2014 - 2025 (USD Million)
  • TABLE 33 Germany research antibodies market, by type, 2014 - 2025 (USD Million)
  • TABLE 34 Germany research antibodies market, by technology, 2014 - 2025 (USD Million)
  • TABLE 35 Germany research antibodies market, by source, 2014 - 2025 (USD Million)
  • TABLE 36 Germany research antibodies market, by application, 2014 - 2025 (USD Million)
  • TABLE 37 Germany research antibodies market, by end - use, 2014 - 2025 (USD Million)
  • TABLE 38 Asia Pacific research antibodies market, by product, 2014 - 2025 (USD Million)
  • TABLE 39 Asia Pacific research antibodies market, by type, 2014 - 2025 (USD Million)
  • TABLE 40 Asia Pacific research antibodies market, by technology, 2014 - 2025 (USD Million)
  • TABLE 41 Asia Pacific research antibodies market, by source, 2014 - 2025 (USD Million)
  • TABLE 42 Asia Pacific research antibodies market, by application, 2014 - 2025 (USD Million)
  • TABLE 43 Asia Pacific research antibodies market, by end - use, 2014 - 2025 (USD Million)
  • TABLE 44 Japan research antibodies market, by product, 2014 - 2025 (USD Million)
  • TABLE 45 Japan research antibodies market, by type, 2014 - 2025 (USD Million)
  • TABLE 46 Japan research antibodies market, by technology, 2014 - 2025 (USD Million)
  • TABLE 47 Japan research antibodies market, by source, 2014 - 2025 (USD Million)
  • TABLE 48 Japan research antibodies market, by application, 2014 - 2025 (USD Million)
  • TABLE 49 Japan research antibodies market, by end - use, 2014 - 2025 (USD Million)
  • TABLE 50 China research antibodies market, by product, 2014 - 2025 (USD Million)
  • TABLE 51 China research antibodies market, by type, 2014 - 2025 (USD Million)
  • TABLE 52 China research antibodies market, by technology, 2014 - 2025 (USD Million)
  • TABLE 53 China research antibodies market, by source, 2014 - 2025 (USD Million)
  • TABLE 54 China research antibodies market, by application, 2014 - 2025 (USD Million)
  • TABLE 55 China research antibodies market, by end - use, 2014 - 2025 (USD Million)
  • TABLE 56 India research antibodies market, by product, 2014 - 2025 (USD Million)
  • TABLE 57 India research antibodies market, by type, 2014 - 2025 (USD Million)
  • TABLE 58 India research antibodies market, by technology, 2014 - 2025 (USD Million)
  • TABLE 59 India research antibodies market, by source, 2014 - 2025 (USD Million)
  • TABLE 60 India research antibodies market, by application, 2014 - 2025 (USD Million)
  • TABLE 61 India research antibodies market, by end - use, 2014 - 2025 (USD Million)
  • TABLE 62 Latin America research antibodies market, by product, 2014 - 2025 (USD Million)
  • TABLE 63 Latin America research antibodies market, by type, 2014 - 2025 (USD Million)
  • TABLE 64 Latin America research antibodies market, by technology, 2014 - 2025 (USD Million)
  • TABLE 65 Latin America research antibodies market, by source, 2014 - 2025 (USD Million)
  • TABLE 66 Latin America research antibodies market, by application, 2014 - 2025 (USD Million)
  • TABLE 67 Latin America research antibodies market, by end - use, 2014 - 2025 (USD Million)
  • TABLE 68 Brazil research antibodies market, by product, 2014 - 2025 (USD Million)
  • TABLE 69 Brazil research antibodies market, by type, 2014 - 2025 (USD Million)
  • TABLE 70 Brazil research antibodies market, by technology, 2014 - 2025 (USD Million)
  • TABLE 71 Brazil research antibodies market, by source, 2014 - 2025 (USD Million)
  • TABLE 72 Brazil research antibodies market, by application, 2014 - 2025 (USD Million)
  • TABLE 73 Brazil research antibodies market, by end - use, 2014 - 2025 (USD Million)
  • TABLE 74 Mexico research antibodies market, by product, 2014 - 2025 (USD Million)
  • TABLE 75 Mexico research antibodies market, by type, 2014 - 2025 (USD Million)
  • TABLE 76 Mexico research antibodies market, by technology, 2014 - 2025 (USD Million)
  • TABLE 77 Mexico research antibodies market, by source, 2014 - 2025 (USD Million)
  • TABLE 78 Mexico research antibodies market, by application, 2014 - 2025 (USD Million)
  • TABLE 79 Mexico research antibodies market, by end - use, 2014 - 2025 (USD Million)
  • TABLE 80 MEA research antibodies market, by product, 2014 - 2025 (USD Million)
  • TABLE 81 MEA research antibodies market, by type, 2014 - 2025 (USD Million)
  • TABLE 82 MEA research antibodies market, by technology, 2014 - 2025 (USD Million)
  • TABLE 83 MEA research antibodies market, by source, 2014 - 2025 (USD Million)
  • TABLE 84 MEA research antibodies market, by application, 2014 - 2025 (USD Million)
  • TABLE 85 MEA research antibodies market, by end - use, 2014 - 2025 (USD Million)
  • TABLE 86 South Africa research antibodies market, by product, 2014 - 2025 (USD Million)
  • TABLE 87 South Africa research antibodies market, by type, 2014 - 2025 (USD Million)
  • TABLE 88 South Africa research antibodies market, by technology, 2014 - 2025 (USD Million)
  • TABLE 89 South Africa research antibodies market, by source, 2014 - 2025 (USD Million)
  • TABLE 90 South Africa research antibodies market, by application, 2014 - 2025 (USD Million)
  • TABLE 91 South Africa research antibodies market, by end - use, 2014 - 2025 (USD Million)
  • TABLE 92 List of Market Players

List of Figures

  • FIG. 1 Market summary
  • FIG. 2 Market trends & outlook
  • FIG. 3 Market segmentation & scope
  • FIG. 4 Market driver relevance analysis (Current & future impact)
  • FIG. 5 Market restraint relevance analysis (Current & future impact)
  • FIG. 6 Penetration & growth prospect mapping
  • FIG. 7 Research antibodies SWOT Analysis, By Factor (Political & legal, economic and technological)
  • FIG. 8 Porter's Five Forces Analysis
  • FIG. 9 Research antibodies market, product outlook: Key takeaways
  • FIG. 10 Research antibodies market: Product movement analysis
  • FIG. 11 Primary antibodies market, 2014 - 2025 (USD Million)
  • FIG. 12 Secondary antibodies market, 2014 - 2025 (USD Million)
  • FIG. 13 Research antibodies market, type outlook: Key takeaways
  • FIG. 14 Research antibodies market: Type movement analysis
  • FIG. 15 Monoclonal antibodies market, 2014 - 2025 (USD Million)
  • FIG. 16 Polyclonal antibodies market, 2014 - 2025 (USD Million)
  • FIG. 17 Research antibodies market, technology outlook: Key takeaways
  • FIG. 18 Research antibodies market: Technology movement analysis
  • FIG. 19 Immunohistochemistry market, 2014 - 2025 (USD Million)
  • FIG. 20 Immunofluorescence market, 2014 - 2025 (USD Million)
  • FIG. 21 Western blotting market, 2014 - 2025 (USD Million)
  • FIG. 22 Flow cytometry market, 2014 - 2025 (USD Million)
  • FIG. 23 Immunoprecipitation market, 2014 - 2025 (USD Million)
  • FIG. 24 ELISA market, 2014 - 2025 (USD Million)
  • FIG. 25 Others market, 2014 - 2025 (USD Million)
  • FIG. 26 Research antibodies market, source outlook: Key takeaways
  • FIG. 27 Research antibodies market: Source movement analysis
  • FIG. 28 Mouse market, 2014 - 2025 (USD Million)
  • FIG. 29 Rabbit market, 2014 - 2025 (USD Million)
  • FIG. 30 Goat market, 2014 - 2025 (USD Million)
  • FIG. 31 Others market, 2014 - 2025 (USD Million)
  • FIG. 32 Research antibodies market, application outlook: Key takeaways
  • FIG. 33 Research antibodies market: Application movement analysis
  • FIG. 34 Infectious diseases market, 2014 - 2025 (USD Million)
  • FIG. 35 Immunology market, 2014 - 2025 (USD Million)
  • FIG. 36 Oncology market, 2014 - 2025 (USD Million)
  • FIG. 37 Stem cells market, 2014 - 2025 (USD Million)
  • FIG. 38 Neurobiology market, 2014 - 2025 (USD Million)
  • FIG. 39 Others market, 2014 - 2025 (USD Million)
  • FIG. 40 Research antibodies market, end - use outlook: Key takeaways
  • FIG. 41 Research antibodies market: End - use movement analysis
  • FIG. 42 Academic & research institutes market, 2014 - 2025 (USD Million)
  • FIG. 43 Contract research organizations market, 2014 - 2025 (USD Million)
  • FIG. 44 Pharmaceutical & biotechnology companies market, 2014 - 2025 (USD Million)
  • FIG. 45 Regional market place: Key takeaways
  • FIG. 46 Regional outlook, 2016 & 2025
  • FIG. 47 North America research antibodies market, 2014 - 2025 (USD Million)
  • FIG. 48 U.S. research antibodies market, 2014 - 2025 (USD Million)
  • FIG. 49 Canada research antibodies market, 2014 - 2025 (USD Million)
  • FIG. 50 Europe research antibodies market, 2014 - 2025 (USD Million)
  • FIG. 51 U.K. research antibodies market, 2014 - 2025 (USD Million)
  • FIG. 52 Germany research antibodies market, 2014 - 2025 (USD Million)
  • FIG. 53 Asia Pacific research antibodies market, 2014 - 2025 (USD Million)
  • FIG. 54 Japan research antibodies market, 2014 - 2025 (USD Million)
  • FIG. 55 China research antibodies market, 2014 - 2025 (USD Million)
  • FIG. 56 India research antibodies market, 2014 - 2025 (USD Million)
  • FIG. 57 Latin America research antibodies market, 2014 - 2025 (USD Million)
  • FIG. 58 Brazil research antibodies market, 2014 - 2025 (USD Million)
  • FIG. 59 Mexico research antibodies market, 2014 - 2025 (USD Million)
  • FIG. 60 MEA research antibodies market, 2014 - 2025 (USD Million)
  • FIG. 61 South Africa research antibodies market, 2014 - 2025 (USD Million)
目次
Product Code: GVR-2-68038-124-5

The global research antibodies market size is expected to reach USD 4.30 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.1% during the forecast period. The market is predominantly driven by growing number of R&D collaborations among various public and private organizations to promote technical advancements in product development activities and disease progression studies. Consistent recommendations and guidelines issued by regulatory organizations for laboratories to facilitate generation of accurate results and ensure high-quality standards are slated to enhance adoption of research antibodies over the coming years. For instance, in May 2016, the International Society for Stem Cell Research issued revised guidelines for cell-based therapies. The revised guidelines were issued with a focus to improve overall efficiency and quality of preclinical studies.

In addition, prominent market players are entering into partnership with R&D entities that are anticipated to open new avenues. In December 2016, Bayer AG and Versant Ventures collaborated to invest around USD 225.0 million for the establishment of a stem cell research facility in Canada to encourage commercialization of regenerative medicine therapies. Increasing prevalence of breast cancer and soaring need for personalized medicine is stirring up the demand for advanced techniques, which in turn is creating ample growth opportunities for the research antibodies market.

Further key findings from the report suggest:

Primary antibodies were the most prominent product segment in 2016 owing to greater specificity leading to increased adoption in research activities. The segment is expected to account for more than 65.0% of the overall market revenue by 2025

On the basis of type, monoclonal antibodies captured substantial share of the market in 2016, owing to high sensitivity for detection of antigens and efficient staining properties with less background noise. The segment is anticipated to rise at a CAGR of 6.6% during the forecast period

Western blotting commanded the leading share in the market, due to benefits such as better immunogenic response from infectious agents and higher cost efficiency. The immunoprecipitation segment is estimated to post the highest CAGR of just over 7.0% during the same period

Mouse antibodies are relatively easier to produce and possess greater specificity, thus resulting in higher adoption in R&D and accounting for the largest market share in 2016.

Oncology accounted for over 36.0% of the overall revenue in 2016 as a consequence of growing cancer population

Pharmaceutical & biotechnology companies will be the leading end users of research antibodies owing to increased adoption in drug development and discovery. The segment is poised to represent more than 61.0% of the overall revenue by 2025.

Contract research organizations are likely to be the most promising end-user segment during the forecast period owing to greater cost efficiency

North America will continue to be the dominant revenue contributor throughout the forecast period owing to local presence of various biotechnology & biopharmaceutical manufacturers striving to compete in the market

Some of the key players in the global arena are Abcam PLC; Agilent Technologies; and Thermo Fisher Scientific, Inc. The research antibodies market is moderately consolidated and highly competitive due to low entry barriers.

Table of Contents

Chapter 1 Executive Summary

  • 1.1 Market Snapshot

Chapter 2 Research Methodology & Scope

  • 2.1 Region Wise Market Calculation
    • 2.1.1 Region Wise Market: Base Estimates
    • 2.1.2 Global Market: CAGR Calculation
  • 2.2 Region based segment share calculation
  • 2.3 List of Secondary Sources

Chapter 3 Research Antibodies Market Variables, Trends& Scope

  • 3.1 Market Segmentation& Scope
  • 3.2 Market Driver Analysis
    • 3.2.1 Increasing investment in R&D
    • 3.2.2 Growing stem cells and neurobiology research
  • 3.3 Market Restraint Analysis
    • 3.3.1 Stringent government regulations
  • 3.4 Penetration & Growth Prospect Mapping
  • 3.5 Research Antibodies - SWOT Analysis, By Factor (Political & legal, economic and technological)
  • 3.6 Industry Analysis - Porter's

Chapter 4 Research Antibodies Market: Product Estimates & Trend Analysis

  • 4.1 Research antibodies Market: Product Movement Analysis
  • 4.2 Primary Antibodies
    • 4.2.1 Primary antibodies market, 2014 - 2025 (USD Million)
  • 4.3 Secondary Antibodies
    • 4.3.1 Secondary antibodies market, 2014 - 2025 (USD Million)

Chapter 5 Research Antibodies Market: Type Estimates & Trend Analysis

  • 5.1 Research Antibodies Market: Type Movement Analysis
  • 5.2 Monoclonal Antibodies
    • 5.2.1 Monoclonal Antibodies market, 2014 - 2025 (USD Million)
  • 5.3 Polyclonal Antibodies
    • 5.3.1 Polyclonal Antibodies market, 2014 - 2025 (USD Million)

Chapter 6 Research Antibodies Market: Technology Estimates & Trend Analysis

  • 6.1 Research antibodies Market: Technology Movement Analysis
  • 6.2 Immunohistochemistry
    • 6.2.1 Immunohistochemistry market, 2014 - 2025 (USD Million)
  • 6.3 Immunofluorescence
    • 6.3.1 Immunofluorescene market, 2014 - 2025 (USD Million)
  • 6.4 Western Blotting
    • 6.4.1 Western blotting market, 2014 - 2025 (USD Million)
  • 6.5 Flow Cytometry
    • 6.5.1 Flow Cytometry market, 2014 - 2025 (USD Million)
  • 6.6 Immunoprecipitation
    • 6.6.1 Immunoprecipitation market, 2014 - 2025 (USD Million)
  • 6.7 Enzyme - linked Immunoassay
    • 6.7.1 ELISA market, 2014 - 2025 (USD Million)
  • 6.8 Others
    • 6.8.1 Others market, 2014 - 2025 (USD Million)

Chapter 7 Research Antibodies Market: Source Estimates & Trend Analysis

  • 7.1 Research antibodies Market: Source Movement Analysis
  • 7.2 Mouse
    • 7.2.1 Mouse market, 2014 - 2025 (USD Million)
  • 7.3 Rabbit
    • 7.3.1 Rabbit market, 2014 - 2025 (USD Million)
  • 7.4 Goat
    • 7.4.1 Goat market, 2014 - 2025 (USD Million)
  • 7.5 Others
    • 7.5.1 Others market, 2014 - 2025 (USD Million)

Chapter 8 Research Antibodies Market: Application Estimates & Trend Analysis

  • 8.1 Research antibodies Market: Application Movement Analysis
  • 8.2 Infectious Diseases
    • 8.2.1 Infectious diseases market, 2014 - 2025 (USD Million)
  • 8.3 Immunology
    • 8.3.1 Immunology market, 2014 - 2025 (USD Million)
  • 8.4 Oncology
    • 8.4.1 Oncology market, 2014 - 2025 (USD Million)
  • 8.5 Stem Cells
    • 8.5.1 Stem Cells market, 2014 - 2025 (USD Million)
  • 8.6 Neurobiology
    • 8.6.1 Neurobiology market, 2014 - 2025 (USD Million)
  • 8.7 Others
    • 8.7.1 Others market, 2014 - 2025 (USD Million)

Chapter 9 Research Antibodies Market: End - use Estimates & Trend Analysis

  • 9.1 Research antibodies Market: End - use Movement Analysis
  • 9.2 Academic & Research Institutes
    • 9.2.1 Academic & research institutes market, 2014 - 2025 (USD Million)
  • 9.3 Contract Research Organizations
    • 9.3.1 Contract research organizations market, 2014 - 2025 (USD Million)
  • 9.4 Pharmaceutical & Biotechnological Companies
    • 9.4.1 Pharmaceutical & biotechnology companies market, 2014 - 2025 (USD Million)

Chapter 10 Research Antibodies Market: Regional Estimates & Trend Analysis, by Product, Type, Technology, Source, Application, End - use

  • 10.1 Research Antibodies Market Share By Region, 2016 & 2025
  • 10.2 North America
    • 10.2.1 North America research antibodies market, 2014 - 2025 (USD Million)
    • 10.2.2 U.S.
      • 10.2.2.1 U.S. research antibodies market, 2014 - 2025 (USD Million)
    • 10.2.3 Canada
      • 10.2.3.1 Canada research antibodies market, 2014 - 2025 (USD Million)
  • 10.3 Europe
    • 10.3.1 Europe research antibodies market, 2014 - 2025 (USD Million)
    • 10.3.2 U.K.
      • 10.3.2.1 U.K. research antibodies market, 2014 - 2025 (USD Million)
    • 10.3.3 Germany
      • 10.3.3.1 Germany research antibodies market, 2014 - 2025 (USD Million)
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific research antibodies market, 2014 - 2025 (USD Million)
    • 10.4.2 Japan
      • 10.4.2.1 Japan research antibodies market, 2014 - 2025 (USD Million)
    • 10.4.3 China
      • 10.4.3.1 China research antibodies market, 2014 - 2025 (USD Million)
    • 10.4.4 India
      • 10.4.4.1 India research antibodies market, 2014 - 2025 (USD Million)
  • 10.5 Latin America
    • 10.5.1 Latin America research antibodies market, 2014 - 2025 (USD Million)
    • 10.5.2 Brazil
      • 10.5.2.1 Brazil research antibodies market, 2014 - 2025 (USD Million)
    • 10.5.3 Mexico
      • 10.5.3.1 Mexico research antibodies market, 2014 - 2025 (USD Million)
  • 10.6 MEA
    • 10.6.1 MEA research antibodies market, 2014 - 2025 (USD Million)
    • 10.6.2 South Africa
      • 10.6.2.1 South Africa research antibodies market, 2014 - 2025 (USD Million)

Chapter 11 Competitive Landscape

  • 11.1 List of Market Players
  • 11.2 Company Profiles
    • 11.2.1 Abcam PLC
      • 11.2.1.1 Company overview
      • 11.2.1.2 Financial Performance
      • 11.2.1.3 Product Benchmarking
      • 11.2.1.4 Strategic Initiatives
    • 11.2.2 Bio - Rad Laboratories
      • 11.2.2.1 Company Overview
      • 11.2.2.2 Financial Performance
      • 11.2.2.3 Product Benchmarking
    • 11.2.3 BD
      • 11.2.3.1 Company Overview
      • 11.2.3.2 Financial Performance
      • 11.2.3.3 Product Benchmarking
    • 11.2.4 Merck Millipore (Danaher)
      • 11.2.4.1 Company Overview
      • 11.2.4.2 Financial Performance
      • 11.2.4.3 Product Benchmarking
    • 11.2.5 Lonza Group
      • 11.2.5.1 Company overview
      • 11.2.5.2 Financial performance
      • 11.2.5.3 Geographic Foothold
      • 11.2.5.4 Product benchmarking
    • 11.2.6 Thermo Fisher Scientific
      • 11.2.6.1 Company overview
      • 11.2.6.2 Financial performance
      • 11.2.6.3 Geographic Foothold
      • 11.2.6.4 Product benchmarking
      • 11.2.6.5 Strategic initiatives
    • 11.2.7 Cell Signalling Technology, Inc.
      • 11.2.7.1 Company overview
      • 11.2.7.2 Product benchmarking
      • 11.2.7.3 Strategic initiatives
    • 11.2.8 F.Hoffmann La Roche Ltd.
      • 11.2.8.1 Company overview
      • 11.2.8.2 Financial performance
      • 11.2.8.3 Product benchmarking
      • 11.2.8.4 Strategic initiatives
    • 11.2.9 Agilent Technologies
      • 11.2.9.1 Company overview
      • 11.2.9.2 Financial performance
      • 11.2.9.3 Product benchmarking
    • 11.2.10 PerkinElmer, Inc.
      • 11.2.10.1 Company overview
      • 11.2.10.2 Financial performance
      • 11.2.10.3 Product benchmarking
      • 11.2.10.4 Strategic initiatives
Back to Top